ArticleHuman vaccines & immunotherapeutics2025
A content analysis of religion and HPV vaccine news coverage in Canada.
Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From hesitancy to confidence: Shaping the future of vaccine messaging.Human vaccines & immunotherapeutics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human papillomavirus (HPV) can cause several cancers. In Canada, HPV vaccination is publicly funded, yet uptake has not consistently reached coverage targets. Media reporting on the perspectives of religious leaders may impact vaccine behavior; however, there has been limited exploration of media depictions of religious perspectives of HPV vaccination in Canada. This study examined the content and tone of news media's depiction of religion and HPV vaccination in Canada. To identify news reports for our content analysis, we searched Canadian Newsstream, Global Newsstream, and Factiva for English language news articles between 2006 and 2024. Published articles covered a 13-year period (2006-2018); no articles were found between 2019 and 2024. We coded 333 articles for: (1) publication information, (2) article tone, (3) description of religious leaders' or members' views toward HPV vaccination, (4) voices represented, and (5) HPV vaccination content reported. Most articles adopted a neutral (72%) or positive (23%) tone toward HPV vaccination. Most articles (97%) focused on Catholic perspectives, with minimal inclusion of other faiths. The most frequently quoted voices in the articles were from school board trustees or administrators (46%), religious leaders (45%), and healthcare professionals (43%). In the articles, medical professionals (68%) and community leaders (45%) were frequently cited as endorsing the HPV vaccine, while religious leaders were less often cited as endorsing vaccination (14%). Support for the vaccine by religious leaders or members primarily focused on disease prevention, while opposition often centered on concerns about promoting sexual activity and misalignment with religious values. As HPV vaccination policies evolve, including endorsement from interfaith leaders and other stakeholders may be important for inclusive health journalism, accurate portrayal of wide-ranging religious perspectives, and the public health priority to increase HPV vaccination.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.